6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid
C20H26FN5O3 — CID 170437916
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid
6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid (PubChem CID 170437916) has the molecular formula C20H26FN5O3 and a molecular weight of 403.46 g/mol. Its IUPAC name is 6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid.
Molecular Properties
| Compound Name | 6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid |
|---|---|
| PubChem CID | 170437916 |
| Molecular Formula | C20H26FN5O3 |
| Molecular Weight | 403.46 g/mol |
| Exact Mass | 403.20 |
| IUPAC Name | 6-[2-[[(2S)-2-fluorobutyl]amino]-4-[(4-hydroxycyclohexyl)amino]pyrimidin-5-yl]pyridine-3-carboxylic acid |
| SMILES | CC[C@H](F)CNc1ncc(-c2ccc(C(=O)O)cn2)c(NC2CCC(O)CC2)n1 |
| InChI | InChI=1S/C20H26FN5O3/c1-2-13(21)10-23-20-24-11-16(17-8-3-12(9-22-17)19(28)29)18(26-20)25-14-4-6-15(27)7-5-14/h3,8-9,11,13-15,27H,2,4-7,10H2,1H3,(H,28,29)(H2,23,24,25,26)/t13-,14?,15?/m0/s1 |
| InChIKey | AKVVBMPNVVOQJS-NFOMZHRRSA-N |
| XLogP | 3.11 |
| TPSA | 120.26 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.46 |
| LogP ≤ 5 | 3.11 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170437916 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.